• Study on Lutetium (177Lu) Vipivotide Tetraxetan for Men with Progressive Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany The Netherlands +3
  • Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Czechia France Greece Italy Poland +2
  • Study on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Slovakia
  • Study on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Germany The Netherlands Poland +3
  • Study of NIDO-361 for Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1
    Investigated drugs:
    Denmark Italy
  • Study on the Effects of Dimethyl Fumarate for Patients with Adrenomyeloneuropathy

    Not recruiting

    4 1 1
    Investigated diseases:
    Spain
  • Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Spain
  • Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    3 1 1
    Belgium Bulgaria Croatia France Italy Poland +3
  • Study on the Effects of Satralizumab for Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

    Not recruiting

    3 1 1
    Investigated diseases:
    France Germany Italy Poland
  • Study on the Effects of VAY736 for Patients with Autoimmune Hepatitis Who Do Not Respond Well to Standard Treatment

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany

powered by